Exploring how sex and gender affect lung disease
Mentoring in Patient Oriented Research in Lung Disease through a Sex and Gender Lens
This study is looking at how lung disease, like COPD, affects men and women differently, so we can better understand their unique risks, symptoms, and treatment responses, while also helping new researchers learn how to consider these differences in their work.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Brigham and Women's Hospital NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-11004143 on NIH RePORTER |
What this research studies
This research investigates the differences in lung disease between males and females, focusing on how these differences impact risk, progression, symptoms, and treatment responses. By utilizing advanced data science techniques, the project aims to analyze genetic and biological factors that contribute to these disparities. The program also emphasizes mentoring new researchers in understanding and applying sex and gender considerations in their work, particularly in the context of chronic obstructive pulmonary disease (COPD). Through this approach, the research seeks to translate findings into practical clinical innovations that can improve patient care.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals diagnosed with chronic obstructive pulmonary disease (COPD) who are interested in how their sex and gender may influence their condition.
Not a fit: Patients with lung diseases unrelated to COPD or those who do not identify with the biological sex or gender constructs being studied may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more personalized and effective treatments for lung diseases based on sex and gender differences.
How similar studies have performed: Previous research has shown promising results in understanding sex and gender differences in other health conditions, suggesting potential for success in this novel approach to lung disease.
Where this research is happening
Boston, United States
- Brigham and Women's Hospital — Boston, United States (Active)
Researchers
- Principal investigator: Demeo, Dawn L — Brigham and Women's Hospital
- Study coordinator: Demeo, Dawn L
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.